In human and mouse hepatocellular carcinoma, PD-1-expressing CD11c+ TI DCs have been identified and have the suppressive capacity to repress CD8+ T cell function (Lim et al., 2016). This evidence concerns the gene PDCD1 and hepatocellular carcinoma.